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Abstract
Introduction: Fat grafts have become a frequent procedure among plastic surgeons due
to their versatility for different pathologies. Different techniques have been described
about graft enhancement to increase survival; in this chapter, with CO2 pneumodissec‐
tion, a technique for improving the biological conditions of the receptor area is exposed.
Already known effects of carboxitherapy, such as vasodilation, enhanced Bohr effect
and  neoangiogenesis,  are  applied  to  increase  the  chance  of  graft  survival.  Tissue
pneumodissection  reduces  the  fat  infiltration  pain,  thus  reducing  the  sedation
requirements.
Materials and methods: Carbon dioxide is infiltrated in the subcutaneous tissue with
a needle before grafting procedure. The amount of CO2 injected varies according to the
recipient area. Sixty patients treated in past 15 months were included in the study.
Patients were followed up every week for the first month, 3 and 6 months postoperative.
Results: Grafts survived in all 40 patients according to clinical observation and follow‐
up. Sedation requirements were minimal. Special interest is the use of this technique
when a scar is adherent to deep planes and skin elasticity is reduced.
Keywords: fat graft, carboxitherapy, receptor area, graft survival, lipofilling, fat graft
enhancement, pneumodissection
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1. Introduction
The introduction of grafts and/or fillers within the subcutaneous tissue implies the creation of
tunnels or planes of dissection within tissue. However, this is not without some significant
degree of trauma to the dermis and hypodermis cellular structure and the fragile microcircu‐
lation and nerves found within these layers.
In addition, the struggle of the instrument against the resistance of these solid cellular tissues
produces pain by transecting nerve endings or compression of the pressure sensors and/or
direct distension of these fragile receptors within the skin.
Until now, the only possible solution to reduce these effects was the application of local
anesthesia of different modalities, that is, blockades, infiltration or tumescent anesthesia. This
implies the introduction of a set volume of liquid and chemicals, which modify the tissue
composition both physically and chemically. This alteration to the biophysical composition of
the host tissue and the direct limitation of surround tissue elasticity and expandability makes
for a suboptimal graft host environment. The ideal environment for graft uptake includes
contact with living tissue for nutrition, abundant vascularization in living tissue and consistent
blood flow through this vascular net. These characteristics provide for nutrition of the graft
and also remove free radicals, toxic for the grafts. We propose a new technique of pneumo‐
dissection using carbon dioxide in the gas state to expand and dissect tissue planes while
preserving delicate microcirculation at the site, enhancing the host area conditions and
decreasing pain to the patient.
2. Characteristics of carbon dioxide
Carbonic acid gas, is also known as carbon dioxide, carbonic anhydride and dry ice in its solid
phase, is composed of one carbon atom and two oxygen atoms, with a chemical formula of CO2.
Its properties have stamped its use as an industrial material as may be seen in fire extinguishers
and welding gas. Commercially, it is added to carbonated beverages, including beer and
champagne, and its solid form, known as “dry ice,” has been used as a refrigerant and as an
abrasive in dry ice blasting.
Within the living cell, a series of reactions in the effort to generate energy in the form of
adenosine triphosphate (ATP) produces one of the main by‐products of aerobic respiration,
that is, carbon dioxide gas (CO2). Within the presence of oxygen, each molecule of glucose
produces 6 molecules of carbon dioxide, 6 molecules of water and up to 30 molecules of ATP.
This CO2 is then excreted through diffusion from the cells into the blood stream, whereby its
binding to hemoglobin ensures its passage to the lungs for exhalation.
Due to the increased solubility of carbon dioxide over oxygen in plasma, each time blood
circulates through the body, 4 vol% of carbon dioxide is removed from the tissues and delivered
to the lungs to be exhaled. However, this can increase 10 times during physical exercise.
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3. Uses of carbon dioxide gas in medicine
Carbon dioxide was first described in 1648 by the chemist Jan Baptist van Helmont upon
observing the mass discrepancy when burning charcoal within a closed vessel. He surmised
that the difference in mass of the ash to the original charcoal had been transmuted into an
invisible substance, which he referred to as a “gas” or “spiritus sylvestre.” Following Jan
Helmont, much work was carried out on the niche properties of carbon dioxide in the 1700s
and 1800s with Adrien‐Jean‐Pierre Thilorier in 1835, describing solid carbon “snow” CO2.
Carbon dioxide’s high purity of 99.9% and nontoxic properties makes it suitable for therapeutic
use. Most commonly employed in insufflation gas for minimal invasive surgery (laparoscopy,
endoscopy and arthroscopies) [1–4] in order to enlarge body cavities, protect and facilitate
manipulation of intra‐abdominal structures.
Possessing no hypersensitivity response, regardless of the volume used, it has been used as a
contrast medium in angiography and venograms [5–7]. Its applicability as a supercritical fluid
state has been marketed within the medical sterilization realm and also when temperatures of
−60°C are reached its therapeutic use in cryotherapy or as local analgesia by external applica‐
tion onto the skin surface.
In 1964, Kumar Patel from the USA invented the CO2 laser, which is still available and which
is one of the most useful varieties of medical, surgical, industrial and military applications.
Other uses have, in the addition to pure oxygen in medical grade oxygen, to help provoke
breathing and stabilize the O2/CO2 balance within blood.
The uses of carbon dioxide gas on the surface and in the depth of the human body have proven
to be highly safe and beneficial in different areas of medicine and surgery. The history of
therapeutic use of carbon dioxide gas by either percutaneous or subcutaneous injection,
otherwise known as carboxitherapy, began in 1932 at a thermal waters station in the Spy of
Royat, France. There, a group of cardiologists utilized CO2 on patients with peripheral and
functional artheropathies (artherosclerotics, Buerger, Raynaud) with significant success. In
1940, Jean Baptiste Romuef [8], a respected cardiologist published his 20‐year experience with
carboxitherapy. By the mid‐1980s, over 400,000 patients had been treated at Royat providing
carboxitherapy as not only an efficient therapeutic method but also a safe one.
The known therapeutic effects of CO2, such as arterial and capillary vasodilation, enhancement
of Bohr and lipolytic effect, increased sympatholytic action and with experimental work
demonstrating its neoangiogenetic effect means that its use continues to expand within the
realms of its therapeutic properties to medicine. There is abundant bibliography that describes
the utilization of carbon dioxide gas in patients with chronic obstructive artery disease and
gangrene who were treated with CO2 injection with significantly good results [9–13].
Also acting on vascular pathologies, in 2002, Toryama et al. [14] showed an excellent improve‐
ment in the peripheral circulation in patients with critical ischemia, with a reduction of 83%
of amputation cases.
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For several decades, we have used the subcutaneous injection of carbon dioxide gas to improve
local circulation of the skin and subcutaneous tissues, to produce detachment of fibrous tissues
and to promote the formation of new collagen in the treated areas [15]. It is also used in its
cryogenic state to perform procedures in cryosurgery.
4. Physiological effects
4.1. Stimulation of blood circulation
Blood circulation is locally increased with pneumodissection due to a vasodilator effect and a
neoangiogenic effect. Vasodilation is produced through two main mechanisms:
• Inflammation
• Acidification
The inflammatory response to an “aggression” is immediate. It physically acts to destroy, dilute
or block the offending agent, but, in turn, this triggers a series of events at the vascularized
connective tissue level, including plasma, in cells circulating in the blood vessels and in the
extravascular components of connective tissue, with the objective to heal and rebuild the
damaged tissue. Acute phase inflammatory mediators, such as histamine, bradykinins and
prostaglandins, produce vasodilation to increase to the local blood flow in order to deliver
white blood cells to the insulted area. Changes in microcirculation occur, increasing the
vascular permeability to cells and proteins.
Histological aspects in the repair process demonstrated the proliferation of small newly
formed blood vessels and fibroblasts [16].
Inside the body, carbon dioxide reacts with water producing carbonic acid. This reaction
acidifies the local medium where CO2is injected. The local increase of H+ stimulates vasodi‐
lation. In this way, carbon dioxide directly in microcirculation of the vascular connective tissue,
promoting vasodilation [17, 18] and an increase in the venous and lymphatic drainage.
According to researchers, this can be a reflection of the increase in parasympathetic activity
by the decrease in sympathetic activity in these tissues. In addition to that, the persistence of
clinical improvement or “temporary cure” of the blood vessel conditions can be explained by
the neoangiogenesis [19], due to the formation of angiogenic factors, and vascular endothelial
growth and fibroblast growth triggered by hypercapnia tissue.
With carboxitherapy, through the infusion of CO2, it is demonstrated that a persistent vasodi‐
lation is identified during assisted laparoscopy, which leads to a significant rise in the concen‐
tration of oxygen (O2) in the local body cavity. Studies with Doppler flow monometry have
demonstrated the action of the carboxitherapy in improving blood flow locally.
4.2. Bohr effect
The affinity of hemoglobin for oxygen depends on the pH of the medium; the acidity stimulates
the release of oxygen thus reducing this affinity. In addition to the acidity, the increase in the
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concentration of carbon dioxide (CO2) as described in the oxygen‐hemoglobin dissociation
curve also lowers the oxygen affinity. The presence of higher levels of CO2 and protons (H+)
in the capillaries of tissues in active metabolism promotes the release of O2 of hemoglobin, the
reciprocal effect occurs in the capillaries of the alveoli of the lungs and the high concentra‐
tion of O2 releases CO2 and H+ of the hemoglobin. This relationship is known as Bohr effect [20,
21].
There is a consensus among authors about the existence of a significant increase in the
concentration of oxygen (O2) locally after subcutaneous infusion of CO2 demonstrating an
increase in the partial pressure of O2. These authors [22, 23] have reported that a decrease in
affinity of hemoglobin for oxygen in the presence of carbon dioxide gas leading to more oxygen
delivery to the cells, which would boost the metabolism of tissues in the region being treated
(potentiation of the Bohr effect).
4.3. Role of CO2 in connective tissue
Carboxitherapy produces a “mechanical trauma” post the insertion of the insufflation cannula
and the direct trauma of the CO2 gas insufflating between tissue planes and creating a form of
pneumodissection. This pneumodissection produces an inflammatory process and the
consequent migration of fibroblasts to the region of insufflation, leading to the subsequent
proliferation of fibroblasts and therefore the synthesis of collagen and activation of other
extracellular matrix proteins such as fibronectin and glycoprotein, which are essential in the
biological processes such as adhesion and cell differentiation, tissue repair, serving as a
substrate for fibrinolytic enzymes and clotting.
Histological studies of the tissues treated with carboxitherapy have found an increase in the
thickness of the dermis, as evidenced by the increased stimulus of neocollagenases. There is
total preservation of the connective tissue layers, including its vascular and neurovascular
structures as evident within these collagen fibers.
5. Carbon dioxide gas as pneumodissector of tissues—carboxitherapy
Insufflating gases within tissue is not an innovative idea in current medicine. Ivån Goni
Moreno, an Argentinean surgeon from the early 1900s, is credited with his operation of
introducing progressive preoperative pneumoperitoneum for the repair of large hernias in
1940. Moreno progressively placed large amounts of room air preoperatively into the perito‐
neal cavity over a period of weeks. With this technique, the patient became adjusted to an
increased intra‐abdominal pressure and tolerated the sudden reduction of the viscera during
the repair, free from respiratory distress.
Currently, with the widespread of laparoscopic procedures, insufflation with carbon dioxide
is widespread in all therapeutic and diagnostic laparoscopy as utilized in general, gynecolog‐
ical and urological surgeries.
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Due to carbon dioxide’s high degree of diffusion, this gas is rapidly absorbed and eliminated,
leaving only the vasodilator effect (pneumodissection) in the tissues, without the increased
risk of fatal air embolism.
Subcutaneous infiltration of CO2 began to be used for aesthetic purposes in the 1970s in France,
with the object of treating cellulite and localized areas of adiposities in the subcutaneous tissue.
More recent work of Brandi et al. [24, 25] showed measurable reductions in maximum
circumference of abdomen, thigh and knee regions with the transcutaneous administration
of CO2 and improved skin irregularity after repeated sessions of carboxitherapy.
6. Theory behind the use of carboxitherapy for pneumodissection during
fat grafting
The ideal conditions for adipose (fat) grafting within tissue includes (1) ease of dissection of
tissue planes with the advancement of the infiltrating cannula, (2) the ability to layer this fat
by placing minimal amounts of adipocytes in multiple tunnels in order to maximize contact
with the surrounding tissues therefore increasing the grafts survival rate, (3) good vasculari‐
zation and oxygenation of tissue recipient site, (4) minimal trauma to reduce the risk of
bruising, (5) the absence of vasoconstriction, (6) the absence of toxic chemicals in the recipient
tissue and (7) good elasticity of the adjacent tissues to comply with the additional volume. The
use of carbon dioxide gas as a pneumodissector of the tissue planes may be the one way to
achieve these ideal conditions in the host tissue.
The resistance of the tissues to the advancement of a needle or cannula is predetermined by
the density of cell structures and fibrosis of the tissue area on the body. Some of the causes of
pain during the introduction of fluids and grafts into tissues are due to the compression of
pressure receptors (baroreceptors) and also by the stretching of the nerve endings by direct
mechanical pressure from the advancing cannula or needle. Also, the pH of the solutions being
injected produces pain and burning. The slow insufflation of the carbon dioxide in its gaseous
state by percutaneous injection produces tissue plane dissection, which subsequently decreas‐
es the tissues’ overall resistance while increasing its three‐dimensional space, yet preserving
the neurovascular characteristics of that tissue by pneumodissecting these structures away
with the advancement of the needle/cannula and therefore decreasing the possibility of direct
pain.
7. Clinical experience
The pneumodissection flow and the total volume of gas infiltrated subcutaneously are
controlled with CARBOTECH F650 from Axt Medical Systems®, with complete control over
the speed and volume of CO2 gas infiltrated (Figure 1).
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Figure 1. Pneumodissector console.
The pneumodissector console is connected to the pure carbon dioxide gas tank. The CO2 is
injected under the control of the surgeon for speed of flow, time of injection and overall
administered dose through a disposable tube with 25G needle attached through luer‐lock. This
needle is then inserted directly under the skin of the patient within the designated site.
The flow of CO2 through the pneumodissector is fixed at 80 ml per minute. Insufflation between
100 and 1000 ml per area depending on the procedure to be carried out and the site on the body
to be performed is undertaken. CO2 easily distributes to all of the injected area and its sur‐
rounding tissue (Figure 2).
Figure 2. Histology of pneumodissected tissue (hematoxylin‐eosin). Left, Normal subcutaneous tissue. Right, Subcuta‐
neous tissue after pneumodissection, note the air spaces between septums and vessels.
During the past 12 months, we have used the pneumodissection technique intraoperatively
prior to the grafting of adipocytes at various quantities in 60 patients (Table 1).
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Area Amount injected (cc) Volume of CO2 infused (cc)
Breast 210 333
Breast 600 707
Breast 560 765
Buttocks 400 580
Buttocks 700 765
Buttocks 800 1000
Buttocks 480 580
Buttocks 550 595
Buttocks 840 843
Buttocks 780 865
Buttocks 440 564
Buttocks 620 789
Buttocks 680 721
Arms 240 469
Arms 225 342
Facial 26 45
Facial 54 89
Facial 32 48
Facial 38 74
Facial 49 107
Buttocks 200 378
Buttocks 680 731
Buttocks 250 379
Buttocks 540 763
Buttocks 780 893
Buttocks 300 389
Breast 150 333
Breast 400 586
Breast 520 555
Breast 460 632
Breast 380 509
Hand 40 100
Hand 50 104
Hand 40 132
Genitalia 30 105
Abdomen 12 40
Abdomen 20 57
Abdomen 10 58
Thigh 180 287
Calf 110 215
Breast 250 380
Breast 550 647
Breast 610 805
Buttocks 450 640
Buttocks 650 700
Buttocks 840 999
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Area Amount injected (cc) Volume of CO2 infused (cc)
Buttocks 430 520
Buttocks 600 700
Buttocks 780 900
Buttocks 700 800
Buttocks 445 507
Buttocks 635 885
Buttocks 600 651
Arms 200 461
Arms 221 302
Facial 22 41
Facial 55 91
Facial 30 44
Facial 34 70
Facial 45 101
Table 1. Patients table. Details of volume of fat grafted and CO2 infused.
Areas of both the body (abdomen, buttocks, arms, breast, and legs) and face have been
successfully pneumodissected prior to fat grafting with clinically superior results compared
to commonly used hydrodissection technique (Figures 3–11).
Figure 3. Patient with abdominal flaccidity, lipodystrophy and gluteal hypoplasia. Preoperative (left) and 3 months
postoperative of TULUA, liposuction and pneumodissection‐assisted fat grafting to gluteal area in the subcutaneous
plane (right).
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Figure 4. Patient with abdominal flaccidity, lipodystrophy and gluteal hypoplasia. Preoperative (left) and 3 months
postoperative of TULUA, liposuction and pneumodissection‐assisted fat grafting to gluteal area in the subcutaneous
plane (right).
Figure 5. Patient with hand aging. Note skin quality, flaccidity and prominence of vascular network (left). Three
months postoperative of pneumodissection‐assisted fat grafting in hands in the subcutaneous plane (right).
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Figure 6. Patient with hand aging. Note skin quality, flaccidity and prominence of vascular network (left). Three
months postoperative of pneumodissection‐assisted fat grafting in hands in the subcutaneous plane (right).
Figure 7. Patient with gluteal hypoplasia (left). After 3 months of pneumodissection‐assisted fat grafting in the gluteal
area in the subcutaneous plane (right).
Figure 8. Patient with gluteal hypoplasia (left). After 3 months of pneumodissection‐assisted fat grafting in the gluteal
area in the subcutaneous plane (right).
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Figure 9. Patient with breast hypoplasia (left). After 3 months of pneumodissection‐assisted fat grafting in breasts in
the subcutaneous plane (right).
Figure 10. Patient with breast hypoplasia (left). After 3 months of pneumodissection‐assisted fat grafting in breasts in
the subcutaneous plane (right).
Figure 11. Patient with breast hypoplasia (left). After 3 months of pneumodissection‐assisted fat grafting in breasts in
the subcutaneous plane (right).
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Upon pneumodissection of the tissue planes, the subsequent ease with which the introduction
and advancement of the infiltrating cannula allows for ease of larger amounts of grafting tissue
(adipocytes) with greater uniformity to be placed, less resistance from normal tissue planes
and decrease in both intra‐ and postoperative discomfort to the patient. There was less bruising
of the skin noted within the postoperative period.
8. Complications and adverse events of carboxitherapy
As already mentioned, carbon dioxide gas is a versatile gas utilized within many industries.
It is a by‐product present in the blood circulation as a consequence of aerobic respiration. Based
on current literature, carboxitherapy can be considered as a safe therapeutic treatment, without
adverse effects or major complications, both local and systemic.
The amount of gas injected during a therapeutic dose of carboxitherapy is below the volume
produced by the body itself. Our body produces 200 cc of CO2 when at rest and during vigorous
exercise this amount may rise to 10 times that value. In addition, the patients in our study
subjected to subcutaneous injections of CO2 show no damage to the connective tissue or its
microcirculation.
Therefore, we know that CO2 works in the affected area and is rapidly eliminated from the
body with no possibility of air embolus. However, in our study, minimal complications were
noted with the administration of subcutaneous CO2 therapy. These included and were limited
to (1) local pain at the injection site of the 25G needle, (2) small bruising and ecchymosis from
the needle entering the dermis, (3) A “cracking sensation” experienced by patients due to the
formation of local emphysema that disappears within 30 minutes of the procedure.
9. Contraindications to carboxitherapy
Contraindications to the treatment include acute myocardial infarction, unstable angina, heart
failure, hypertension, acute thrombophlebitis, gangrene or localized infections at the site
therapy, epilepsy, respiratory failure, renal failure, pregnancy and psychiatric disorder. But in
any case, these patients would not be candidates for an elective body contouring surgery. So,
in healthy patients with usual comorbidities, there are no contraindications.
10. Conclusion
Carbon dioxide is an abundant gas found in every living species on Earth. Its role in many
industries, including medicine, have stemmed from its early discovery in 1648. With respect
to its effect on both the skin and subdermal layers, CO2 has sound physiological principles
confirmed through histological studies.
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Our technique of pneumodissection prior to adipocyte grafting has worked with these
principles in mind. Using CO2 to establish volume within given tissue planes yet preserv‐
ing the fragile microcirculation of the tissue is a valuable prerequisite to the survival of
the graft.
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